Overview
The primary objective of this study is to characterize the safety profile of sotorasib.
Eligibility
Inclusion Criteria:
- Adult (≥ 18 years) as of the index date.
- KRAS p.G12C-mutated locally advanced or metastatic NSCLC.
- Received at least 1 dose of sotorasib.
- Receipt of at least 1 prior systemic therapy before use of sotorasib.
- Obtained ICF, if required.
Exclusion Criteria:
- Documentation of being a non-Chinese ethnicity.